Esragül AKINCI, Hurrem BODUR, Bircan KAYAASLAN, Aliye BAŞTUĞ, Selim Sırrı EREN, Sümeyye KAZANCIOĞLU, Halide ASLANER, Ayşe BUT, Meltem Arzu YETKİN

Does the course of laboratory parameters help us to predict the outcome of CCHF?

Background/aim: This study was performed to identify the characteristics distinguishing fatal and nonfatal cases of patients diagnosed with Crimean Congo hemorrhagic fever (CCHF). Materials and methods: A total of 92 patients with confirmed diagnosis of CCHF in 2009 2013 were included in the study. Results: A high level of urea and aPTT on the third day of hospital stay, diarrhea, somnolence, and the interval from the beginning of the symptoms to hospital admission were independently associated with fatality. Each 10-unit increase in aPTT and urea levels increased the fatality rate by 3.379-fold and 1.236-fold, respectively. Delay in hospital admission increased the fatality rate 1.453-fold for each day of delay. When comparing first and third admission-day laboratory values, the increase in leukocyte counts and the decrease in CPK, urea, creatinine, aPTT, PT, INR, and hemoglobin levels were significant in nonfatal cases. Conclusion: This study showed that the course of these laboratory tests helps us to predict the outcome of the disease. In a few days of hospitalization, persistence or progress of the abnormal laboratory parameters may warn us about poor prognosis.

PDF

___

1. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antivir Res 2004; 64: 145160.
2. Appannanavar SB, Mishra B. An update on Crimean Congo hemorrhagic fever. J Glob Infect Dis 2011; 3: 285292.
3. Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, Torunoglu MA. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 20022007. Int J Infect Dis 2009; 13: 380386.
4. Bodur H, Akinci E, Ascioglu S, Öngürü P, Uyar Y. Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey. Emerg Infect Dis 2012; 18: 640642.
5. Jamil B, Hasan RS, Sarwari AR, Burton J, Hewson R, Clegg C. Crimean-Congo hemorrhagic fever: experience at a tertiary care hospital in Karachi, Pakistan. T Roy Soc Trop Med H 2005; 99: 577584.
6. Akinci E, Bodur H, Leblebicioglu H. Pathogenesis of CrimeanCongo hemorrhagic fever. Vector-Borne Zoonot 2013; 13: 429437.
7. Leblebicioglu H. Crimean-Congo hemorrhagic fever in Eurasia. Int J Antimicrob Ag 2010; 36: S43S46.
8. Çevik MA, Erbay A, Bodur H, Gülderen E, Baştuğ A, Kubar A, Akıncı E. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008; 12: 374379.
9. Akyol M, Özçelik S, Engin A, Hayta SB, Biçici F. Cutaneous manifestations of Crimean-Congo haemorrhagic fever: morbilliform eruptions may reflect a favorable outcome and not low platelet levels. Eur J Dermatol 2010; 20: 523524.
10. Sannikova IV, Pacechnikov VD, Maleev VV. Respiratory lesions in Crimean-Congo hemorrhagic fever. Ter Arkh 2007; 79: 2023 (in Russian with abstract in English).
11. Dogan OT, Engin A, Salk I, Epozturk K, Eren SH, Elaldi N, Bakir M, Dokmetas I, Akkurt I. Evaluation of respiratory findings in Crimean-Congo hemorrhagic fever. SE Asian J Trop Med 2011; 42: 11001105.
12. Yilmaz GR, Buzgan T, Torunoglu MA, Safran A, Irmak H, Com S, Uyar Y, Carhan A, Ozkaya E, Ertek M et al. A preliminary report on Crimean-Congo haemorrhagic fever in Turkey, MarchJune 2008. Eurosurveillance 2008; 14: 18953.
13. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989; 11: 794800.
14. Hatipoglu CA, Bulut C, Yetkin MA, Ertem GT, Erdinc FS, Kilic EK, Sari T, Kinikli S, Oral B, Demiroz AP et al. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey. Scand J Infect Dis 2010; 42: 516521.
15. Ozturk B, Tutuncu E, Kuscu F, Gurbuz Y, Sencan I, Tuzun H. Evaluation of factors predictive of the prognosis in CrimeanCongo hemorrhagic fever: new suggestions. Int J Infect Dis 2012; 16: e89e93.
16. Yilmaz G, Koksal I, Topbas M, Yilmaz H, Aksoy F. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria. J Clin Virol 2010; 47: 361 365.
17. Cevik MA, Erbay A, Bodur H, Eren SS, Akinci E, Sener K, Ongürü P, Kubar A. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis 2007; 45: e96e10.